Dopamine as the wind of the psychotic fire:
new evidence from brain imaging studies

by
Laruelle M, Abi-Dargham A
Department of Psychiatry,
Columbia University College of Physicians and Surgeons,
and
New York State Psychiatric Institute,
New York 10032, USA.
laruelle@neuron.cpmc.columbia.edu
J Psychopharmacol 1999 Dec; 13(4):358-71


ABSTRACT

Abnormalities of dopamine function in schizophrenia are suggested by the common antidopaminergic properties of antipsychotic medications. However, direct evidence of a hyperdopaminergic state in schizophrenia has been difficult to demonstrate, given the difficulty of measuring dopamine transmission in the living human brain. This situation is rapidly changing. Recent developments in positron emission tomography and single-photon emission tomographic techniques enabled measurement of acute fluctuation of synaptic dopamine in the vicinity of D2 receptors. Using this technique, we, and others, measured the increase in dopamine transmission following acute amphetamine challenge in untreated patients with schizophrenia and matched healthy subjects. Following a brief overview of these new brain imaging techniques, the main results derived with this method in patients with schizophrenia are described: (1) amphetamine-induced dopamine release is elevated in patients with schizophrenia, supporting the idea that schizophrenia is associated with dysregulation of dopamine transmission; (2) following amphetamine, hyperactivity of dopamine transmission is associated with activation of psychotic symptomatology; (3) this dysregulation of dopamine release is not a long-term consequence of previous neuroleptic treatment, and is detected in never-medicated patients experiencing a first episode of the illness; and (4) in contrast, this exaggerated response of the dopamine system to amphetamine exposure is not detected in patients studied during a period of illness stabilization, suggesting that the hyperdopaminergic state associated with schizophrenia fluctuates over time. In conclusion, a hyperdopaminergic state might be present in schizophrenia during the initial episode and subsequent relapses, but not during periods of remission. This finding has important consequences for the development of new treatment strategies for the remission phase.
Ice
AD/HD
History
Adderall
Serotonin
Pregnancy
VTA/glutamate
Self-medication
Worms on speed
Dopamine uptake
Canine narcolepsy
Dextroamphetamine
Appetite suppressants
Methamphetamine FAQ
Dopaminergics/psychosis
Methamphetamine/narcolepsy
Amphetamine withdrawal/depression



Refs
and further reading

amphetamines.com
HOME
HedWeb
Nootropics
erythroxylum-coca.com
Cannabis.net
Future Opioids
BLTC Research
MDMA/Ecstasy
Superhappiness?
Utopian Surgery?
The Good Drug Guide
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World